Welcome to chemicalbook!
WhatsApp
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >BRD5529
BRD5529
  • BRD5529

BRD5529 NEW

Price $52
Package 2mg
Supply Ability: 10g
Update Time: 2026-07-27

Product Details

Product Name: BRD5529 CAS No.: 1358488-78-4
Supply Ability: 10g Release date: 2026/07/27

Product Introduction

Bioactivity

NameBRD5529
DescriptionBRD5529 is a selective inhibitor of the CARD9-E3 ubiquitin ligase TRIM62 protein-protein interaction, with an IC50 value of 8.6 μM. BRD5529 directly and selectively binds CARD9, disrupts TRIM62 recruitment, inhibits TRIM62-mediated ubiquitinylation, and suppresses CARD9 activation. BRD5529 is therefore applicable to investigations involving innate immune signaling, ubiquitination pathways, inflammatory regulation, and CARD9-associated immune responses.
In vitroBRD5529 exhibits potent dose-dependent inhibitory activity against the CARD9-TRIM62 interaction, with an IC50 value of 8.6 μM[1]. BRD5529 (200 μM, 0–50 min; 200 μM, 2–4 h) suppresses CARD9-dependent signaling in innate immune cells[1]. BRD5529 (40 μM) dose-dependently inhibits TRIM62-mediated CARD9 ubiquitination in vitro[1].
In vivoBRD5529 (0.1 or 1.0 mg/kg; i.p.; daily, for 2 weeks) does not produce significant changes in daily or final weight gain, shows no major differences in proinflammatory cytokine levels, and does not cause significant alterations in lung, liver, or kidney pathology scores of Pneumocystis pneumonia (PCP) mice model[2].
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility InformationDMSO : 100 mg/mL (214.8 mM), Sonication is recommended.
KeywordsCARD9-E3 ubiquitin ligase TRIM62 | BRD5529
Inhibitors RelatedT521 | NAcM-OPT | Nutlin-3 | Yucasin | BC-1293 | EN219 | NSC232003 | Auxinole | Indole-3-carbinol | Idasanutlin | TRIM25 ligand-1 | Direct Black 38

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

Recommended supplier

Product name Price   Suppliers Update time
$52.00
VIP3Y
TargetMol Chemicals Inc.
2026-07-27
$52.00
VIP3Y
TargetMol Chemicals Inc.
2025-08-22

TargetMol Chemicals Inc.

4YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY